The JPAC Document Library is a repository for documents which influence the Blood Transfusion and Tissue Transplantation Services in the United Kingdom. Some of the documents are issued by, or on b…
Statement of intent JPAC is committed to making our Web site accessible to all Internet users and to meeting the requirements of the Disability Discrimination Act 1995.…
These guidelines are under the continuing review of the Standing Advisory Committees for the Care and Selection of Donors (SACCSD) and for Transfusion Transmitted Infection (SACTTI). This is to ens…
These guidelines are under the continuing review of the Standing Advisory Committee for Tissues and Cellular Therapy Products (SACTCTP) and for Transfusion Transmitted Infection (SACTTI). This is t…
The GDRI is under the continuing review of the Standing Advisory Committees for the Care and Selection of Donors (SACCSD) and for Transfusion Transmitted Infection (SACTTI). This is to ensure that …
framework-organisation-chart.jpg (41KB)
lines-of-accountability.jpg (61KB)
Minutes of the JPAC meeting 16-03-2023.pdf (210KB)
18.5: References Metcalfe P, Watkins NA, Ouwehand WH, Kaplan C, Newman P, Kekomaki R, De Haas M, Aster R, Shibata Y, Smith J, Kiefel V, Santoso S. (2003). Nomenclature of Human P…
18.4: Patient testing 18.4.1: HPA typing Patients should be typed for HPA following the guidelines for donor HPA typing with the following exceptions: A p…
18.3: Donor testing 18.3.1: HPA typing Donors whose products may be used for fetal/neonatal transfusions should be HPA typed twice using samples collected on diff…
18.2: Methods 18.2.1: HPA typing methods HPA types should be determined using antibody-based and/or DNA/PCR-based techniques that have been validated in the laboratory.…
18.1: Reagent manufacture/reference preparations 18.1.1: HPA typing reagents There are several human platelet antigen (HPA) genotyping and phenotyping techniques. The <…
16.3: Terminology and nomenclature All HLA assignments, irrespective of the method, must comply with the latest report of the WHO Nomenclature Committee for Factors of the HLA System.
15.2: Clinical applications of blood group molecular typing Various clinical applications of blood group molecular typing are listed below: Fetal typing:1
14.1: Safety precautions All human cells should be treated as potentially infectious. Materials should be handled and discarded according to in-house documented procedures for potentiall…
13.5: Fetomaternal haemorrhage estimation by flow cytometry 13.5.1 Indications for testing For any D negative pregnant mother where the screening test indicates a fetomaternal…
13.6: Post-examination All patient records and test results should be maintained according to the requirements of the Caldicott Report (1997)8 and Data Protection…